Literature DB >> 2559903

The non-effect of pirenzepine in dietary resistant irritable bowel syndrome.

J Gilvarry, A Kenny, J F Fielding.   

Abstract

No subjective or objective evidence of beneficial effect was observed from the use of Pirenzepine in irritable bowel syndrome (IBS) patients who had not responded to a high fibre diet.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2559903     DOI： 10.1007/BF02943704

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  3 in total

1.  Domperidone treatment in the irritable bowel syndrome.

Authors:  J F Fielding
Journal:  Digestion       Date:  1982       Impact factor: 3.216

2.  Double blind trial of trimebutine in the irritable bowel syndrome.

Authors:  J F Fielding
Journal:  Ir Med J       Date:  1980-10

3.  Timolol treatment in the irritable bowel syndrome.

Authors:  J F Fielding
Journal:  Digestion       Date:  1981       Impact factor: 3.216
  3 in total
  2 in total

Review 1.  IBS and the role of otilonium bromide.

Authors:  Guy Boeckxstaens; Enrico S Corazziari; Fermín Mearin; Jan Tack
Journal:  Int J Colorectal Dis       Date:  2012-11-22       Impact factor: 2.571

Review 2.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.